Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,449 | 63,379 | 109,872 | 151,795 | 145,826 |
| Marketable Securities | 198,701 | 234,429 | 219,960 | 214,458 | 237,603 |
| Receivables | 4,380 | 6,674 | 103 | 4,945 | 4,400 |
| TOTAL | $315,700 | $318,839 | $337,622 | $379,280 | $395,883 |
| Non-Current Assets | |||||
| PPE Net | 8,320 | 8,480 | 9,436 | 10,071 | 11,452 |
| Other Non-Current Assets | 11,846 | 10,052 | 12,715 | 13,036 | 8,523 |
| TOTAL | $20,166 | $18,532 | $22,151 | $23,107 | $19,975 |
| Total Assets | $335,866 | $337,371 | $359,773 | $402,387 | $415,858 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,565 | 6,873 | 4,815 | 5,246 | 7,632 |
| Accrued Expenses | 32,757 | 23,940 | 29,478 | 33,258 | 34,720 |
| Other current liabilities | 6,967 | 6,497 | 5,117 | 17,774 | 15,376 |
| TOTAL | $48,596 | $42,539 | $44,563 | $61,355 | $57,728 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,381 | 2,751 | 4,073 | 5,385 | 4,091 |
| TOTAL | $1,381 | $2,751 | $4,073 | $5,385 | $4,091 |
| Total Liabilities | $49,977 | $45,290 | $48,636 | $66,740 | $61,819 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,726 | 80,366 | 79,257 | 78,049 | 77,709 |
| Common Shares | 82 | 79 | 78 | 78 | 78 |
| Retained earnings | -545,196 | -497,935 | -451,416 | -418,966 | -391,732 |
| Other shareholders' equity | -915 | -1,077 | -677 | -129 | -11 |
| TOTAL | $285,889 | $292,081 | $311,137 | $335,647 | $354,039 |
| Total Liabilities And Equity | $335,866 | $337,371 | $359,773 | $402,387 | $415,858 |